AMGEN (AMGN) has a profit margin of 20.96%, above the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
As of the most recent data (March 2026), AMGN shows a profit margin of 20.96%. That compares with 17.41% in the prior-year period — up 20.4% year over year. That is above the Healthcare sector average of 15.58%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AMGN's profit margin is now 20.96% (was 17.41%) — a 20.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether AMGEN is outperforming or lagging.
The Healthcare sector average profit margin is about 15.58%. AMGEN is at 20.96%, which is higher that average. That is roughly 34.5% above the sector mean. Use the comparison chart on this page to see how AMGN stacks up against individual peers as well.
That compares with 17.41% in the prior-year period — up 20.4% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare AMGEN with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has AMGEN's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 20.96%) with ownership activity and broader fundamentals.